Cathepsin K Substrate II Fluorogenic

CAT:
952-B2014038
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Cathepsin K Substrate II Fluorogenic - image 1

Cathepsin K Substrate II Fluorogenic

  • Description:

    Cathepsin K Substrate II Fluorogenic_x000D_ Catalog number: B2014038_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mg_x000D_ Molecular Weight or Concentration: 918.91 g/mol_x000D_ Supplied as: Powder_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: −20°C_x000D_ Keywords: Cathepsin K Substrate II, Fluorogenic_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Lecaille F, Chazeirat T, Bojarski KK, Renault J, Saidi A, Prasad VGNV, Samsonov S, Lalmanach G. Rat cathepsin K: Enzymatic specificity and regulation of its collagenolytic activity Biochim Biophys Acta Proteins Proteom. 2020 Feb;1868(2):140318._x000D_ 2: Mukherjee K, Chattopadhyay N. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy Biochem Pharmacol. 2016 Oct 1;117:10-9._x000D_ 3: Li Z, Hou WS, Escalante-Torres CR, Gelb BD, Bromme D. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate J Biol Chem. 2002 Aug 9;277(32):28669-76._x000D_ 4: Hwang HS, Chung HS. Preparation of active recombinant cathepsin K expressed in bacteria as inclusion body Protein Expr Purif. 2002 Aug;25(3):541-6._x000D_ 5: Li Z, Hou WS, Brmme D. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates Biochemistry. 2000 Jan 25;39(3):529-36._x000D_ 6: Lecaille F, Chowdhury S, Purisima E, Brmme D, Lalmanach G. The S2 subsites of cathepsins K and L and their contribution to collagen degradation Protein Sci. 2007 Apr;16(4):662-70._x000D_ 7: Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets Curr Pharm Des. 2007;13(4):387-403._x000D_ 8: de Melo Pereira D, Davison N, Habibovi P. Human osteoclast formation and resorptive function on biomineralized collagen Bioact Mater. 2021 Jul 15;8:241-252._x000D_ 9: de Maat S, Clark CC, Boertien M, Parr N, Sanrattana W, Hofman ZLM, Maas C. Factor XII truncation accelerates activation in solution J Thromb Haemost. 2019 Jan;17(1):183-194._x000D_ 10: Oliveira M, Torquato RJ, Alves MF, Juliano MA, Brmme D, Barros NM, Carmona AK. Improvement of cathepsin S detection using a designed FRET peptide based on putative natural substrates Peptides. 2010 Apr;31(4):562-7. _x000D_ _x000D_ Products Related to Cathepsin K Substrate II Fluorogenic can be found at Substrates
  • Short Description:

    Catalog Number: B2014038 (1 mg)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5